References
1. Kunin CM. Chemoprophylaxis and suppressive therapy in the
management of urinary tract infections. Journal of
Antimicrobial Chemotherapy. 1994;33(suppl_A):51-62.
2. Foxman B. Epidemiology of urinary tract infections:
Incidence, morbidity, and economic costs. Disease-a-Month.
2003;49(2):53-70.
3. Diagnosis and classification of diabetes mellitus. Diabetes
care. 2009;32 Suppl 1(Suppl 1):S62-7.
4. Abu-Ashour W, Twells L, Valcour J, Randell A, Donnan J,
Howse P, et al. The association between diabetes mellitus and
incident infections: a systematic review and meta-analysis of
observational studies. BMJ Open Diabetes Research and Care.
2017;5(1):e000336.
5. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes
atlas: global estimates of the prevalence of diabetes for 2011
and 2030. Diabetes research and clinical practice.
2011;94(3):311-21.
6. Cheraghi J, Zargushi M, Khyabani PK, Nasri S. Effects of
Parsley (Petroselinum Crispum) Hydroalcoholic Extract on
Spermatogenesis and Pituitary-Gonadal Axis in
Streptozotocin-Induced Diabetic Male Rat. Iranian Journal of
Veterinary Medicine. 2021;15(4).
7. Abdul-Sahib KY. Study of ciprofloxacin resistant Escherichia
coli (CREC) in type 2 diabetic patients with symptomatic
urinary tract infections. Iraqi J Comm Med. 2008;21:58-63.
8. Baqai R, Aziz M, Rasool G. Urinary tract infections in
diabetic patients and biofilm formation of uropathogens. Infect
Dis J Pak. 2008;17(1):21-4.
9. Yadav K, Prakash S, Serayi R, Shilpkar T, Shrestha S.
Antimicrobial susceptibility test of pathogens isolated from
urinary tract infection suspected cases. Janaki Medical College
Journal of Medical Science. 2014;2(1):28-34.
10. Geerlings SE, Stolk RP, Camps M, Netten PM, Collet TJ,
Hoepelman A, et al. Risk factors for symptomatic urinary tract
infection in women with diabetes. Diabetes care.
2000;23(12):1737-41.
11. Szucs S, Cserhati I, Csapo G, Balazs V. The relation
between diabetes mellitus and infections of the unirary tract. A
clinical, qualitative and quantitative bacteriological study
based upon 300 diabetics and 200 controls. The American
journal of the medical sciences. 1960;240:186-91.
12. Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ,
List JF. Urinary tract infections in patients with diabetes
treated with dapagliflozin. Journal of Diabetes and its
Complications. 2013;27(5):473-8.
13. Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W,
Stolk RP, Hoepelman AI. Cytokine secretion is impaired in
women with diabetes mellitus. European journal of clinical
investigation. 2000;30(11):995-1001.
14. Borj M, Taghizadehborojeni S, Shokati A, Sanikhani N,
Pourghadamyari H, Mohammadi A, et al. Urinary tract
infection among diabetic patients with regard to the risk
factors, causative organisms and their antimicrobial
susceptibility profiles at Firoozgar Hospital, Tehran, Iran.
International Journal of Life Science and Pharma Research.
2017;7(3):L38-L47.
15. Hamdan HZ, Kubbara E, Adam AM, Hassan OS, Suliman
SO, Adam I. Urinary tract infections and antimicrobial
sensitivity among diabetic patients at Khartoum, Sudan.
Annals of clinical microbiology and antimicrobials.
2015;14(1):1-6.
16. Goldstein FW. Antibiotic susceptibility of bacterial strains
isolated from patients with community-acquired urinary tract
infections in France. Multicentre Study Group. Eur J Clin
Microbiol Infect Dis. 2000;19(2):112-7.
17. Halaji M, Feizi A, Mirzaei A, Sedigh Ebrahim-Saraie H,
Fayyazi A, Ashraf A, et al. The Global Prevalence of Class 1
Integron and Associated Antibiotic Resistance in Escherichia
coli from Patients with Urinary Tract Infections, a Systematic
Review and Meta-Analysis. Microb Drug Resist.
2020;26(10):1208-18.
18. Bakht M, Alizadeh SA, Rahimi S, Kazemzadeh Anari R,
Rostamani M, Javadi A, et al. Phenotype and genetic
determination of resistance to common disinfectants among
biofilm-producing and non-producing Pseudomonas
aeruginosa strains from clinical specimens in Iran. BMC
microbiology. 2022;22(1):124.
19. Parte A, Krieg NR, Ludwig W, Whitman WB, Hedlund BP,
Paster BJ, et al. Bergey''''s Manual of Systematic Bacteriology:
Volume 4: The Bacteroidetes, Spirochaetes, Tenericutes
(Mollicutes), Acidobacteria, Fibrobacteres, Fusobacteria,
Dictyoglomi, Gemmatimonadetes, Lentisphaerae,
Verrucomicrobia, Chlamydiae, and Planctomycetes: Springer
Science & Business Media; 2011.
20. Patterson JE, Andriole VT. Bacterial urinary tract infections
in diabetes. Infect Dis Clin North Am. 1997;11(3):735-50.
21. Aswani SM, Chandrashekar U, Shivashankara K, Pruthvi B.
Clinical profile of urinary tract infections in diabetics and nondiabetics. Australas Med J. 2014;7(1):29-34.
22. Sewify M, Nair S, Warsame S, Murad M, Alhubail A,
Behbehani K, et al. Prevalence of Urinary Tract Infection and
Antimicrobial Susceptibility among Diabetic Patients with
Controlled and Uncontrolled Glycemia in Kuwait. J Diabetes
Res. 2016;2016:6573215.
23. Al Benwan K, Al Sweih N, Rotimi VO. Etiology and
antibiotic susceptibility patterns of community- and hospital-
108 Shahsavari et al / Archives of Razi Institute, Vol. 79, No. 1 (2024) 98-108
acquired urinary tract infections in a general hospital in
Kuwait. Med Princ Pract. 2010;19(6):440-6.
24. Nicolle LE. Urinary tract infections in special populations:
diabetes, renal transplant, HIV infection, and spinal cord
injury. Infect Dis Clin North Am. 2014;28(1):91-104.
25. Adeleye O, Ajala T, Adekoya OA, Adeleye AI. Effective
Dose Regimen of STZ for STZ-induced Diabetes in a Rat
Model. Iranian Journal of Veterinary Medicine. 2023.
26. Khani A, Khorasgani EM. Investigating the Effect of
Hydroalcoholic Extract of Eryngos on Plasma Concentration of
Blood Glucose, Blood Cells and Pancreatic Tissue in Diabetic
Rats. Iranian Journal of Veterinary Medicine. 2021;15(4).
27. Shahsavani M, Norouzi P, Kalalianmoghaddam H, Teimouri
M. Effects of Kudzu Root on Oxidative Stress and
Inflammation in Streptozotocin-Induced Diabetic Rats. Iranian
Journal of Veterinary Medicine. 2022.
28. Simkhada R. Urinary tract infection and antibiotic sensitivity
pattern among diabetics. Nepal Med Coll J. 2013;15(1):1-4.
)